Dewpoint Therapeutics is the first company founded to apply the emerging discipline of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions have pathways that are regulated by condensates or arise from the dysfunction of condensates — including cancer, neurodegeneration, and metabolic disease. Dewpoint scientists are working in Boston, MA, and Dresden, Germany, to translate condensate biology into treatments for the toughest diseases.
Location: United States, Massachusetts, Boston
Employees: 51-200
Total raised: $227M
Founded date: 2018
Investors 5
| Date | Name | Website |
| - | Innovation... | innovation... |
| 07.02.2022 | 3E Biovent... | 3ebiovc.co... |
| 17.07.2021 | ARCH Ventu... | archventur... |
| - | Timefolio ... | timefolioc... |
| - | EcoR1 Capi... | ecor1cap.c... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 03.02.2022 | Series C | $150M | - | 3ebiovc.co... |
| 29.09.2020 | Series B | $77M | - | prnewswire... |
Mentions in press and media 7
| Date | Title | Description | Source |
| 04.02.2022 | Dewpoint Therapeutics Announces Completion of $150 Million S... | - | 3ebiovc.co... |
| 03.02.2022 | Dewpoint Therapeutics Completes $150M Series C Financing | Dewpoint Therapeutics, Inc., a Boston, MA-based biomolecular condensates company, completed a $150m ... | finsmes.co... |
| 06.01.2021 | Dewpoint Announces Collaboration with Pfizer to Develop Pote... | BOSTON, Jan. 6, 2021 /PRNewswire/ -- Dewpoint Therapeutics, the biomolecular condensates company, ... | prnewswire... |
| 29.09.2020 | Dewpoint Therapeutics to put 'pedal to the metal' with $77M ... | Dewpoint Therapeutics was founded because “the pharma industry has kind of been fighting with one ar... | fiercebiot... |
| 29.09.2020 | Dewpoint Therapeutics to put 'pedal to the metal' with $77M ... | Dewpoint Therapeutics was founded because “the pharma industry has kind of been fighting with one ar... | fiercebiot... |
| 29.09.2020 | Dewpoint Therapeutics Raises $77M Series B Financing to Adva... | BOSTON, Sept. 29, 2020 /PRNewswire/ -- Dewpoint Therapeutics, the biomolecular condensates company... | prnewswire... |
| 29.09.2020 | Dewpoint Therapeutics Raises $77M Series B | Dewpoint Therapeutics, the biomolecular condensates company, today announced it has raised $77 milli... | citybizlis... |